The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia
瑞伐美尼(revumenib)是一种治疗KMT2A重排或NPM1突变型白血病的menin抑制剂。
期刊:Nature
影响因子:48.5
doi:10.1038/s41586-023-05812-3
Issa, Ghayas C; Aldoss, Ibrahim; DiPersio, John; Cuglievan, Branko; Stone, Richard; Arellano, Martha; Thirman, Michael J; Patel, Manish R; Dickens, David S; Shenoy, Shalini; Shukla, Neerav; Kantarjian, Hagop; Armstrong, Scott A; Perner, Florian; Perry, Jennifer A; Rosen, Galit; Bagley, Rebecca G; Meyers, Michael L; Ordentlich, Peter; Gu, Yu; Kumar, Vinit; Smith, Steven; McGeehan, Gerard M; Stein, Eytan M